Search research articles
Contact Us
Filters
Showing results (241-250 of 264) with videos related to
Page
of 27
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1996
Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636
C W Lin, B R Bianchi, T R Miller, et al.
Molecular Pharmacology
|
December 1, 1989
Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33)
C W Lin, M W Holladay, R W Barrett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 1, 1991
Characterization by image cytometry of duct epithelial proliferative disease of the breast
E B King, K L Chew, J D Hom, et al.
European Journal of Pharmacology
|
May 14, 1999
Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell line
T R Miller, R D Taber, E J Molinari, et al.
AJNR. American Journal of Neuroradiology
|
November 3, 2018
Pipeline Diameter Significantly Impacts the Long-Term Fate of Jailed Side Branches during Treatment of Intracranial Aneurysms
T R Miller, M J Kole, E J Le, et al.
Molecular Pharmacology
|
March 1, 1991
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors
C W Lin, K Shiosaki, T R Miller, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
Tetrapeptide CCK-A agonists: effect of backbone N-methylations on in vitro and in vivo CCK activity
M W Holladay, H Kopecka, T R Miller, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 21, 2003
D-alanine piperazine-amides: novel non-imidazole antagonists of the histamine H3 receptor
R Faghih, K Phelan, T A Esbenshade, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue
M J Bennett, A L Nikkel, B R Bianchi, et al.
Journal of Medicinal Chemistry
|
January 21, 1994
Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus
R L Elliott, H Kopecka, M J Bennett, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 264) with videos related to
Sort By:
Page
of 27
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1996
Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636
C W Lin, B R Bianchi, T R Miller, et al.
Molecular Pharmacology
|
December 1, 1989
Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33)
C W Lin, M W Holladay, R W Barrett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 1, 1991
Characterization by image cytometry of duct epithelial proliferative disease of the breast
E B King, K L Chew, J D Hom, et al.
European Journal of Pharmacology
|
May 14, 1999
Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell line
T R Miller, R D Taber, E J Molinari, et al.
AJNR. American Journal of Neuroradiology
|
November 3, 2018
Pipeline Diameter Significantly Impacts the Long-Term Fate of Jailed Side Branches during Treatment of Intracranial Aneurysms
T R Miller, M J Kole, E J Le, et al.
Molecular Pharmacology
|
March 1, 1991
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors
C W Lin, K Shiosaki, T R Miller, et al.
Journal of Medicinal Chemistry
|
March 4, 1994
Tetrapeptide CCK-A agonists: effect of backbone N-methylations on in vitro and in vivo CCK activity
M W Holladay, H Kopecka, T R Miller, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 21, 2003
D-alanine piperazine-amides: novel non-imidazole antagonists of the histamine H3 receptor
R Faghih, K Phelan, T A Esbenshade, et al.
Journal of Medicinal Chemistry
|
May 27, 1994
CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue
M J Bennett, A L Nikkel, B R Bianchi, et al.
Journal of Medicinal Chemistry
|
January 21, 1994
Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus
R L Elliott, H Kopecka, M J Bennett, et al.
Page
of 27